[Use of polyplatillen in chemotherapy of advanced pancreatic cancer].
The results of Poliplatillen clinical application in 108 patients with advanced pancreatic cancer were analyzed. The use of Poliplatillen in adjuvant regimen improves the long-term results of treatment. The mean survival time was increased on 2.9 months, which was statistically significant, mediana survival was increased on 1.5 months, 10% of patients alived 20 months, 20%--16 months. Survival of patients of control group did not exceed 12 months.